Tapewire

Nasdaq · USD

AKBA

Akebia Therapeutics, Inc.

Export transactions ↓
Tapewire entity
6105
SEC CIK
0001517022
Parsed reports
275

Last 12 months

Inside the activity.

1 purchase rows · 16 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 2026015
Mar 202610
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 12, 2022 Filed May 16, 2022 20:04 UTC
Cotreau ViolettaSVP, Chief Accounting Officer
GrantCommon Stock 150,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-004030 · primarydocument.xml · nonDerivative · entry 1

Cotreau Violetta · CIK 0001841934 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 219,954

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The restricted stock units will vest in full on the first anniversary of the grant date, subject to the reporting person's continued service with the Issuer on such vesting date.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 21:11 UTC
Dahan MichelSVP, Chief Operating Officer
SaleCommon Stock 1,232 $2.17 $2,674.30
Disclosure

SEC source: 0001562180-22-002163 · primarydocument.xml · nonDerivative · entry 5

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 297,017

F5 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.

F6 · balance_after: Includes 1,500 shares of the Issuers common stock purchased on June 30, 2021 and 1,500 shares of the Issuers common stock purchased on December 31, 2021, each under the Issuers 2014 Amended and Restated Employee Stock Purchase Plan.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 21:11 UTC
Dahan MichelSVP, Chief Operating Officer
SaleCommon Stock 6,873 $2.17 $14,919.22
Disclosure

SEC source: 0001562180-22-002163 · primarydocument.xml · nonDerivative · entry 4

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,249

F4 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 21:11 UTC
Dahan MichelSVP, Chief Operating Officer
SaleCommon Stock 6,873 $2.17 $14,919.22
Disclosure

SEC source: 0001562180-22-002163 · primarydocument.xml · nonDerivative · entry 3

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 302,122

F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2019.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 02:25 UTC
Butler John P.Director · CEO and President
SaleCommon Stock 4,131 $2.17 $8,967.16
Disclosure

SEC source: 0001562180-22-002166 · primarydocument.xml · nonDerivative · entry 5

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,403,247

F6 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 02:25 UTC
Butler John P.Director · CEO and President
SaleCommon Stock 25,031 $2.17 $54,334.79
Disclosure

SEC source: 0001562180-22-002166 · primarydocument.xml · nonDerivative · entry 4

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,407,378

F5 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2019.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 02:25 UTC
Butler John P.Director · CEO and President
SaleCommon Stock 24,811 $2.17 $53,857.24
Disclosure

SEC source: 0001562180-22-002166 · primarydocument.xml · nonDerivative · entry 3

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,432,409

F4 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 02:12 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 1,100 $2.17 $2,387.77
Disclosure

SEC source: 0001562180-22-002165 · primarydocument.xml · nonDerivative · entry 4

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,663

F4 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.

F5 · balance_after: Includes 1,500 shares of the Issuers common stock purchased on December 31, 2021, under the Issuers 2014 Amended and Restated Employee Stock Purchase Plan.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 02:12 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 6,556 $2.17 $14,231.11
Disclosure

SEC source: 0001562180-22-002165 · primarydocument.xml · nonDerivative · entry 3

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,263

F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 02:10 UTC SaleCommon Stock 957 $2.17 $2,077.36
Disclosure

SEC source: 0001562180-22-002162 · primarydocument.xml · nonDerivative · entry 4

Faulkingham Dell · CIK 0001776024 · SVP, CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,841

F4 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 02:10 UTC SaleCommon Stock 5,748 $2.17 $12,477.18
Disclosure

SEC source: 0001562180-22-002162 · primarydocument.xml · nonDerivative · entry 3

Faulkingham Dell · CIK 0001776024 · SVP, CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,798

F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 02:10 UTC
Hadas Nicole R.SVP, Chief Legal Officer
SaleCommon Stock 1,078 $2.17 $2,340.01
Disclosure

SEC source: 0001562180-22-002161 · primarydocument.xml · nonDerivative · entry 5

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 304,241

F5 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.

F6 · balance_after: Includes 1,500 shares of the Issuers common stock purchased on June 30, 2021 and 1,500 shares of the Issuers common stock purchased on December 31, 2021, each under the Issuers 2014 Amended and Restated Employee Stock Purchase Plan.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 02:10 UTC
Hadas Nicole R.SVP, Chief Legal Officer
SaleCommon Stock 6,556 $2.17 $14,231.11
Disclosure

SEC source: 0001562180-22-002161 · primarydocument.xml · nonDerivative · entry 4

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 302,319

F4 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 02:10 UTC
Hadas Nicole R.SVP, Chief Legal Officer
SaleCommon Stock 6,873 $2.17 $14,919.22
Disclosure

SEC source: 0001562180-22-002161 · primarydocument.xml · nonDerivative · entry 3

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,875

F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2019.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 02:09 UTC
Spellman David ASVP, CFO and Treasurer
SaleCommon Stock 803 $2.17 $1,743.07
Disclosure

SEC source: 0001562180-22-002160 · primarydocument.xml · nonDerivative · entry 3

Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,599

F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:11 UTC
Dahan MichelSVP, Chief Operating Officer
GrantEmployee Stock Option (Right to buy) · Derivative 200,000 $0.00 Strike: $2.16 $0.00
Disclosure

SEC source: 0001562180-22-002163 · primarydocument.xml · derivative · entry 6

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2032-02-28

F7 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:11 UTC
Dahan MichelSVP, Chief Operating Officer
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-002163 · primarydocument.xml · nonDerivative · entry 2

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,995

F2 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One-third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:11 UTC
Dahan MichelSVP, Chief Operating Officer
SaleCommon Stock 6,555 $2.15 $14,124.71
Disclosure

SEC source: 0001562180-22-002163 · primarydocument.xml · nonDerivative · entry 1

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 258,995

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:25 UTC
Butler John P.Director · CEO and President
GrantEmployee Stock Option (Right to buy) · Derivative 739,700 $0.00 Strike: $2.16 $0.00
Disclosure

SEC source: 0001562180-22-002166 · primarydocument.xml · derivative · entry 10

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 739,700

Underlying: Common Stock · 739,700 shares

Expires 2032-02-28

F7 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:25 UTC
Butler John P.Director · CEO and President
GrantCommon Stock 293,125 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-002166 · primarydocument.xml · nonDerivative · entry 2

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,457,220

F3 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One-third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:25 UTC
Butler John P.Director · CEO and President
SaleCommon Stock 25,053 $2.15 $53,984.20
Disclosure

SEC source: 0001562180-22-002166 · primarydocument.xml · nonDerivative · entry 1

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,164,095

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.

F2 · balance_after: Includes: (i) the 1,248 shares of common stock that were described in the amendment on Form 4/A filed by the reporting person with the SEC on February 18, 2022, (ii) 1,500 shares of the Issuer's common stock purchased on each of June 30, 2021 and December 31, 2021, each under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan, and (iii) 32,747 shares of common stock that represent a change from indirect to direct ownership of shares previously reported as beneficially owned by the reporting person.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:12 UTC
Burke Steven KeithSVP, Chief Medical Officer
GrantEmployee Stock Option (Right to buy) · Derivative 225,000 $0.00 Strike: $2.16 $0.00
Disclosure

SEC source: 0001562180-22-002165 · primarydocument.xml · derivative · entry 5

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Stock · 225,000 shares

Expires 2032-02-28

F6 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:12 UTC
Burke Steven KeithSVP, Chief Medical Officer
GrantCommon Stock 60,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-002165 · primarydocument.xml · nonDerivative · entry 2

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 223,819

F2 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One-third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:12 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 7,400 $2.15 $15,945.52
Disclosure

SEC source: 0001562180-22-002165 · primarydocument.xml · nonDerivative · entry 1

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,819

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:12 UTC
Cotreau ViolettaSVP, Chief Accounting Officer
GrantEmployee Stock Option (Right to buy) · Derivative 70,000 $0.00 Strike: $2.16 $0.00
Disclosure

SEC source: 0001562180-22-002164 · primarydocument.xml · derivative · entry 3

Cotreau Violetta · CIK 0001841934 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2032-02-28

F3 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:12 UTC
Cotreau ViolettaSVP, Chief Accounting Officer
GrantCommon Stock 40,833 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-002164 · primarydocument.xml · nonDerivative · entry 2

Cotreau Violetta · CIK 0001841934 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,954

F2 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One-third of the restricted stock units will become vested on the first anniversary of the grant date; and the remaining 2/3 of the Shares will vest in substantially equal quarterly installments thereafter, at the beginning of each of the following eight calendar quarters, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:12 UTC
Cotreau ViolettaSVP, Chief Accounting Officer
SaleCommon Stock 3,946 $2.15 $8,502.84
Disclosure

SEC source: 0001562180-22-002164 · primarydocument.xml · nonDerivative · entry 1

Cotreau Violetta · CIK 0001841934 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,121

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:10 UTC GrantEmployee Stock Option (Right to buy) · Derivative 200,000 $0.00 Strike: $2.16 $0.00
Disclosure

SEC source: 0001562180-22-002162 · primarydocument.xml · derivative · entry 5

Faulkingham Dell · CIK 0001776024 · SVP, CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2032-02-28

F5 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:10 UTC GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-002162 · primarydocument.xml · nonDerivative · entry 2

Faulkingham Dell · CIK 0001776024 · SVP, CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,546

F2 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One-third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:10 UTC SaleCommon Stock 6,479 $2.15 $13,960.95
Disclosure

SEC source: 0001562180-22-002162 · primarydocument.xml · nonDerivative · entry 1

Faulkingham Dell · CIK 0001776024 · SVP, CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,546

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:10 UTC
Hadas Nicole R.SVP, Chief Legal Officer
GrantEmployee Stock Option (Right to buy) · Derivative 200,000 $0.00 Strike: $2.16 $0.00
Disclosure

SEC source: 0001562180-22-002161 · primarydocument.xml · derivative · entry 6

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2032-02-28

F7 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:10 UTC
Hadas Nicole R.SVP, Chief Legal Officer
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-002161 · primarydocument.xml · nonDerivative · entry 2

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315,748

F2 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One-third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:10 UTC
Hadas Nicole R.SVP, Chief Legal Officer
SaleCommon Stock 6,555 $2.15 $14,124.71
Disclosure

SEC source: 0001562180-22-002161 · primarydocument.xml · nonDerivative · entry 1

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,748

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:09 UTC
Spellman David ASVP, CFO and Treasurer
GrantEmployee Stock Option (Right to buy) · Derivative 225,000 $0.00 Strike: $2.16 $0.00
Disclosure

SEC source: 0001562180-22-002160 · primarydocument.xml · derivative · entry 4

Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Stock · 225,000 shares

Expires 2032-02-28

F4 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:09 UTC
Spellman David ASVP, CFO and Treasurer
GrantCommon Stock 60,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-002160 · primarydocument.xml · nonDerivative · entry 2

Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,402

F2 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:09 UTC
Spellman David ASVP, CFO and Treasurer
SaleCommon Stock 7,400 $2.15 $15,945.52
Disclosure

SEC source: 0001562180-22-002160 · primarydocument.xml · nonDerivative · entry 1

Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,402

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:11 UTC
Cotreau ViolettaSVP, Chief Accounting Officer
SaleCommon Stock 5,833 $2.29 $13,335.40
Disclosure

SEC source: 0001562180-22-000236 · primarydocument.xml · nonDerivative · entry 1

Cotreau Violetta · CIK 0001841934 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,067

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of the reporting person's restricted stock units granted on December 31, 2020.

Read SEC document
November 01, 2021 Filed Nov 3, 2021 20:47 UTC
FRIESON RONDirector
GrantStock Option (Right to buy) · Derivative 80,200 $0.00 Strike: $3.13 $0.00
Disclosure

SEC source: 0001562180-21-006801 · primarydocument.xml · derivative · entry 1

FRIESON RON · CIK 0001890219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,200

Underlying: Common Stock · 80,200 shares

Expires 2031-11-01

F1 · derivative.exercise_date: The options will vest over three years: 33 1/3 % of the options will vest on the first anniversary of the grant date and the remaining 66 2/3 % will vest ratably on the first day of each calendar quarter thereafter

Read SEC document
September 30, 2021 Filed Oct 1, 2021 20:06 UTC
Spellman David ASVP, CFO and Treasurer
GrantEmployee Stock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $2.88 $0.00
Disclosure

SEC source: 0001562180-21-006188 · primarydocument.xml · derivative · entry 1

Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2031-09-30

F1 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
August 31, 2021 Filed Sep 2, 2021 20:07 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 1,042 $2.83 $2,948.86
Disclosure

SEC source: 0001562180-21-005744 · primarydocument.xml · nonDerivative · entry 1

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,219

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on August 30, 2019.

F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2021 under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan.

Read SEC document
June 07, 2021 Filed Jun 9, 2021 16:26 UTC SaleCommon Stock 4,567 $3.32 $15,163.35
Disclosure

SEC source: 0001562180-21-004152 · primarydocument.xml · nonDerivative · entry 1

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,997

F1 · kind: This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 5, 2020.

F2 · price: This transaction was executed in multiple trades at prices ranging from $3.3201 USD to $3.325 USD; the price reported above reflects the weighted average sale price.

Read SEC document
June 02, 2021 Filed Jun 3, 2021 21:28 UTC
Wolf MylesDirector
GrantStock Option (Right to buy) · Derivative 20,100 $0.00 Strike: $3.37 $0.00
Disclosure

SEC source: 0001562180-21-004031 · primarydocument.xml · derivative · entry 2

Wolf Myles · CIK 0001808317 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 20,100 shares

Expires 2031-06-02

F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 02, 2021 Filed Jun 3, 2021 21:28 UTC
Wolf MylesDirector
GrantCommon Stock 13,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-004031 · primarydocument.xml · nonDerivative · entry 1

Wolf Myles · CIK 0001808317 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,981

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 02, 2021 Filed Jun 3, 2021 21:27 UTC GrantStock Option (Right to buy) · Derivative 20,100 $0.00 Strike: $3.37 $0.00
Disclosure

SEC source: 0001562180-21-004028 · primarydocument.xml · derivative · entry 2

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 20,100 shares

Expires 2031-06-02

F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 02, 2021 Filed Jun 3, 2021 21:27 UTC GrantCommon Stock 13,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-004028 · primarydocument.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,586

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 02, 2021 Filed Jun 3, 2021 21:27 UTC
ADAMS ADRIANDirector
GrantStock Option (Right to buy) · Derivative 20,100 $0.00 Strike: $3.37 $0.00
Disclosure

SEC source: 0001562180-21-004026 · primarydocument.xml · derivative · entry 2

ADAMS ADRIAN · CIK 0001248144 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 20,100 shares

Expires 2031-06-02

F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 02, 2021 Filed Jun 3, 2021 21:27 UTC
ADAMS ADRIANDirector
GrantCommon Stock 13,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-004026 · primarydocument.xml · nonDerivative · entry 1

ADAMS ADRIAN · CIK 0001248144 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,100

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 02, 2021 Filed Jun 3, 2021 21:27 UTC GrantStock Option (Right to buy) · Derivative 20,100 $0.00 Strike: $3.37 $0.00
Disclosure

SEC source: 0001562180-21-004029 · primarydocument.xml · derivative · entry 2

ROGERS MICHAEL W · CIK 0001244159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 20,100 shares

Expires 2031-06-02

F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 02, 2021 Filed Jun 3, 2021 21:27 UTC GrantCommon Stock 13,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-004029 · primarydocument.xml · nonDerivative · entry 1

ROGERS MICHAEL W · CIK 0001244159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,329

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 02, 2021 Filed Jun 3, 2021 17:26 UTC GrantStock Option (Right to buy) · Derivative 20,100 $0.00 Strike: $3.37 $0.00
Disclosure

SEC source: 0001562180-21-004027 · primarydocument.xml · derivative · entry 2

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 20,100 shares

Expires 2031-06-02

F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.